Detalhe da pesquisa
1.
Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma.
J Immunol
; 211(7): 1067-1072, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37722095
2.
In vivo imaging of nanoparticle-labeled CAR T cells.
Proc Natl Acad Sci U S A
; 119(6)2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101971
3.
Antigen processing and presentation-related signature-derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and in vitro validation.
J Gene Med
; 26(1): e3586, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37655535
4.
Tumor microenvironment phenotypes and prognostic evaluation tools for osteosarcoma characterized by different prognostic outcomes and immunotherapy responses.
J Gene Med
; 26(1): e3572, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525871
5.
Necrotizing apoptosis-related genes prognosis and treatment effect analysis of osteosarcoma in children.
J Gene Med
; 26(1): e3646, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100138
6.
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activity.
Cancer Immunol Immunother
; 73(5): 77, 2024 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38554158
7.
Racial disparities in the management and outcomes of primary osseous neoplasms of the spine: a SEER analysis.
J Neurooncol
; 166(2): 293-301, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38225469
8.
Manual and Semi-Automated Measurement and Calculation of Osteosarcoma Treatment Effect Using Whole Slide Image and Qupath.
Pediatr Dev Pathol
; 27(1): 32-38, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943723
9.
A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma.
Mol Ther
; 31(8): 2342-2359, 2023 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37312451
10.
Osteosarcoma-targeted Cu and Ce based oxide nanoplatform for NIR II fluorescence/magnetic resonance dual-mode imaging and ros cascade amplification along with immunotherapy.
J Nanobiotechnology
; 22(1): 151, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575943
11.
Switchable CAR T cell strategy against osteosarcoma.
Cancer Immunol Immunother
; 72(8): 2623-2633, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062034
12.
Collaborative Design of MgO/FeOx Nanosheets on Titanium: Combining Therapy with Regeneration.
Small
; 19(5): e2204852, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36464630
13.
FePSe3 -Nanosheets-Integrated Cryogenic-3D-Printed Multifunctional Calcium Phosphate Scaffolds for Synergistic Therapy of Osteosarcoma.
Small
; 19(38): e2303636, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217971
14.
Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
Pediatr Blood Cancer
; 70(11): e30649, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37638816
15.
MiRNA-520a-3p combined with folic acid conjugated Fe2O3@PDA multifunctional nanoagents for MR imagine and antitumor gene-photothermal therapy.
Nanotechnology
; 34(37)2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192608
16.
Metachronous Osteosarcoma, A Differential Diagnosis to be Considered in Children With Osteosarcoma: A Review of Literature and a Case From Our Center.
J Pediatr Hematol Oncol
; 45(3): 105-110, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251795
17.
Biodegradable FePS3 nanoplatform for efficient treatment of osteosarcoma by combination of gene and NIR-II photothermal therapy.
J Nanobiotechnology
; 21(1): 224, 2023 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443019
18.
Engineering a triple-functional magnetic gel driving mutually-synergistic mild hyperthermia-starvation therapy for osteosarcoma treatment and augmented bone regeneration.
J Nanobiotechnology
; 21(1): 201, 2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37365598
19.
CKM and TERT dual promoters drive CRISPR-dCas9 to specifically inhibit the malignant behavior of osteosarcoma cells.
Cell Mol Biol Lett
; 28(1): 52, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415116
20.
Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?
Clin Orthop Relat Res
; 481(11): 2154-2163, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37145140